Literature DB >> 492021

Embolism in thyrotoxic atrial fibrillation.

R W Yuen, D H Gutteridge, P L Thompson, J S Robinson.   

Abstract

Of 210 patients with thyrotoxicosis, 21 (10%) had atrial fibrillation. Five of these patients (24%) had systemic emboli (which were multiple in three patients, one of whom died) and two other patients had pulmonary embolism. Embolic disease is common in thyrotoxic atrial fibrillation, and anticoagulant therapy should be considered for all patients.

Entities:  

Mesh:

Year:  1979        PMID: 492021     DOI: 10.5694/j.1326-5377.1979.tb119428.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  11 in total

Review 1.  Risk factors for stroke and primary prevention of stroke in atrial fibrillation.

Authors:  A Laupacis; D Singer; A Jacobsen; M Dunn; J Dalen; G Albers
Journal:  J Thromb Thrombolysis       Date:  1999-01       Impact factor: 2.300

2.  Heart failure in thyrotoxicosis, an approach to management.

Authors:  R P Choudhury; J MacDermot
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335

Review 3.  Embolic risk in atrial fibrillation that arises from hyperthyroidism: review of the medical literature.

Authors:  Elie Traube; Neil L Coplan
Journal:  Tex Heart Inst J       Date:  2011

4.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  Circulation       Date:  2014-03-28       Impact factor: 29.690

5.  Atrial fibrillation and embolism.

Authors:  J A Milliken
Journal:  Can Med Assoc J       Date:  1983-06-15       Impact factor: 8.262

Review 6.  Thyroid, hemostasis and thrombosis.

Authors:  F Marongiu; C Cauli; S Mariotti
Journal:  J Endocrinol Invest       Date:  2004-12       Impact factor: 4.256

Review 7.  Atrial Fibrillation and Its Association with Endocrine Disorders.

Authors:  Manjari Devidi; Avanija Buddam; Sunil Dacha; D Sudhaker Rao
Journal:  J Atr Fibrillation       Date:  2014-02-28

8.  Heart Failure in Thyrotoxic Cardiomopathy: Extracorporeal Membrane Oxygenation Treatment for Graves' Disease.

Authors:  Joseph Allencherril; Itamar Birnbaum
Journal:  J Extra Corpor Technol       Date:  2015-12

9.  Cerebrovascular Accident due to Thyroid Storm: Should We Anticoagulate?

Authors:  Alex Gonzalez-Bossolo; Alexis Gonzalez-Rivera; Santiago Coste-Sibilia
Journal:  Case Rep Endocrinol       Date:  2016-08-15

10.  ECG changes in patients with primary hyperthyroidism.

Authors:  Ishtiaque Hussain Baladi; Ayesha Aslam Rai; Syed Masroor Ahmed
Journal:  Pan Afr Med J       Date:  2018-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.